HealthWell: Amyloidosis

Not Funded
About
The HealthWell: Amyloidosis program offers crucial financial assistance to patients undergoing treatment for Amyloidosis, specifically covering a range of medications including Ozurdex, Pomalyst, Rayos, Revlimid, and others. HealthWell: Amyloidosis aims to ease the financial burden by providing copay and premium support, with an emphasis on accessibility and ease of enrollment through online and phone applications, ensuring patients can focus on their treatment without financial stress.
Insurance requirements: Commercially insured, Medicare / Medicaid
Enrollment Forms
Enrollment Form
Benefits
$8000 annual maximum benefit
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: Yes
Activation Required: No
Program Details
Please note that this copay/premium fund may cover offlabel drugs
No minimum copay reimbursement amount and No minimum premium reimbursement amount
Eligible patients can complete the application process online or by phone
Patients must submit, ‘Statement of Treatment’ (completed & signed by provider), copy of insurance cards, and prescription cards, by fax (18002827692) within 30 days of application
Approved patients will receive a letter detailing assistance. They can access their grant by using their ‘HealthWell Foundation Copayment Assistance Card’, by asking their provider’s office or pharmacy to direct bill with HealthWell, or by paying up front and submitting claim to HealthWell for direct reimbursement
Patients will have one full year to use the grant before needing to reenroll (grants are given on a firstcome, firstserved basis)
For grants to remain active, the first complete reimbursement request must be received within 90 days of approval date, and must continue at least every 90 days
Grants with no activity for over 90 days will be considered inactive and closed
Patients who are approved for a grant but do not use a portion of their grant money may not be able to reenroll